ARCHIVES

FDA Tightens Conflict of Interest Rules For Advisors.

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | March 23, 2007

Download PDF Visit The Full Archive

Related Articles

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

May 30, 2014

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

Low Budget, Empty Beds, Lack Of Vision Beset Clinical Center, NIH Officials Say.

June 20, 2008

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

High-Dose Chemo Can Cure Rare Pediatric Brain Tumor

February 25, 2005

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980